Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia

Clin Infect Dis. 2018 May 2;66(10):1640-1641. doi: 10.1093/cid/cix1090.

Authors

Wesley H Self¹, Richard G Wunderink², Seema Jain³, Kathryn M Edwards⁴, Carlos G Grijalva⁵; Etiology of Pneumonia in the Community (EPIC) Study Investigators

Affiliations

¹ Department of Emergency Medicine, Nashville, Tennessee.
² Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
³ Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ Department of Pediatrics, Nashville, Tennessee.
⁵ Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.

PMID: 29360954
DOI: 10.1093/cid/cix1090

No abstract available

Publication types

Comment

MeSH terms

Adult
Community-Acquired Infections*
Humans
Pneumonia*
Procalcitonin

Substances

Procalcitonin

Grants and funding